Landi, D., Archer, G., Driscoll, T., Lipp, E., Archambault, B., Thompson, E., … Ashley, D. (2020). EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. In Neuro-Oncology (Vol. 22, pp. iii306–iii306). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noaa222.136

Landi, Daniel, Gary Archer, Timothy Driscoll, Eric Lipp, Bridget Archambault, Eric Thompson, Charlene Flahiff, et al. “EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS.” In Neuro-Oncology, 22:iii306–iii306. Oxford University Press (OUP), 2020. https://doi.org/10.1093/neuonc/noaa222.136.

Landi D, Archer G, Driscoll T, Lipp E, Archambault B, Thompson E, et al. EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. In: Neuro-Oncology. Oxford University Press (OUP); 2020. p. iii306–iii306.

Landi, Daniel, et al. “EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS.” Neuro-Oncology, vol. 22, no. Supplement_3, Oxford University Press (OUP), 2020, pp. iii306–iii306. Crossref, doi:10.1093/neuonc/noaa222.136.

Landi D, Archer G, Driscoll T, Lipp E, Archambault B, Thompson E, Flahiff C, Jaggers D, Hahn K, Healy P, Ramirez L, Herndon J, Schroeder K, Sampson J, Ashley D. EPCT-13. CMV PP65 RNA-PULSED DENDRITIC CELL VACCINES FOR PEDIATRIC GLIOBLASTOMA AND MEDULLOBLASTOMA: PHASE I TRIAL RESULTS. Neuro-Oncology. Oxford University Press (OUP); 2020. p. iii306–iii306.